Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Waldenstrom Macroglobulinemia 1Prostatic Neoplasms 1Leukemia 1Glioblastoma 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Radiosurgery 31Magnetic Resonance Spectroscopy 16Temozolomide 12pembrolizumab 11Nivolumab 10Specimen Handling 8Ipilimumab 8Bevacizumab 8Radiotherapy 7Mental Status and Dementia Tests 7Memantine 7abemaciclib 5Blood Specimen Collection 5Biopsy 4trastuzumab deruxtecan 3entrectinib 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Sodium Chloride 3Saline Solution 3Receptors, Interleukin-8B 3Proton Therapy 3Dexamethasone 3Cyclophosphamide 3trametinib 2pertuzumab 2osimertinib 2fluciclovine F-18 2contrast agent BR1 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Valacyclovir × 90 days × Clear all
NCT06914479 2026-05-27

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

University of Michigan Rogel Cancer Center

Phase 1 Recruiting
11 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡